Biocon - Global Healthcare Company
 
About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
 
  About Us
  Research & Development
  Branded Formulations
  - biocondiabetology.com
  - biocononcotherapeutics.com
  Investors
  - Annual Report 2012
  Financial Results FY2013
  - Transcript of FY2013 Conf Call
  - Investors Presentation
  Facilities Virtual Tour
  - Biocon
  - Syngene
  - Clinigene
  Downloads
  - Biocon Profile
  - CMD Profile
  - Video Gallery
  Follow us on
  Linked In
   
     
  Biocon is an emerging global biopharmaceutical enterprise

focused on delivering affordable innovation. It is committed to

reduce therapy costs of chronic diseases like diabetes, cancer

and autoimmune diseases by leveraging India's cost advantage

to deliver affordable healthcare solutions to patients, partners

and healthcare systems across the globe.


more...

 
   
   
   
   
Kiran Mazumdar-Shaw on FY13 Results



Biocon FY13 Results

Stock Update
  Latest Press Release
 

Apr 25, 2013:
Biocon delivers a strong performance of 18% Revenue Growth in FY13 driven by an evolving Product Portfolio and Research Services


more...

  Media Coverage
  Apr 27, 2013:
Biocon net up over two-fold at Rs 249 crore in Q4...


more...
 

Biocon Foundation


Arogya Raksha Yojana

   
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Clinigene International

    Linked In   
  * Disclaimer | Authorised Users               © 2013, Biocon. All Rights Reserved